Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Immuno-Oncology Webinar: Immunotherapy Cancer Combinations – When, Who and at What Price?

This article was originally published in Scrip

Executive Summary

Immuno-oncology may be seen as the future of cancer therapy, but it is combination therapy that is the future of immuno-oncology. The potential to use different types of these novel immune-acting products together to boost cancer control is as exciting in its potential as it is mind-boggling in its complexity. In this third Immuno-Oncology Webinar in Informa's series, our team of experts use exclusive data and insight to delve into the world of combination cancer immunotherapies.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel